Biomarker Discovery Outsourcing Services Market Size

Biomarker Discovery Outsourcing Services Market Size

Biomarker Discovery Outsourcing Services Market size was valued USD 11.4 billion in 2023 and is estimated to witness 12.7% CAGR from 2024 to 2032. The expansion of the market is propelled by a rising need for personalized medicine, prompting a surge in R&D activities. Also, the need for affordable therapeutic options have driven the demand for precision medicines.

To get key market trends

  Download Free Sample

For instance, the U.S. Food and Drug Administration (FDA) approved 12 new personalized medicines and expanded the applications of several existing treatments. Similarly, FDA has also authorized two innovative siRNA therapies and provided guidelines for advancing gene & cell-based therapies along with the approved use of five such therapies. Thus, the shift toward personalized medicine is significantly reliant on the identification and validation of biomarkers, thereby augmenting the market growth.

Biomarker discovery outsourcing services plays crucial role as a measurable indicator of biological processes or conditions, in disease diagnosis, prognosis, and treatment monitoring. These outsourcing services integrate a range of activities, including sample analysis, data interpretation, and assay development.